ArticleOncotarget2017

Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma.

Simone Treiger Sredni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.